Vijaya Diagnostic Centre Ltd. · NSE:VIJAYA
Vijaya Diagnostic Centre — Q1 FY27 Earnings Presentation
52 slides from Vijaya Diagnostic Centre's earnings presentation, Aug 6, 2026
Slide 1: Exchange covering letter for investor presentation
August 06, 2026 To To The Listing Department, The Corporate Relations Department, National Stock Exchange of India Limited BSE Limited NSE Symbol: VIJAYA BSE Scrip Code: 543350 Dear Sir/Madam, Sub: Investor Presentation Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Require
Slide 2: Q1 FY27 Earnings Presentation
Q1 FY27 Earnings Presentation August 6, 2026 Q2 & H1 FY25 Earnings Presentation, November 07, 2024
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Vijaya Diagnostic Centre Limited (the ‘Company’), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for
Slide 4: Q1 FY27 Performance Snapshot
Q1 FY27 Performance Snapshot Strategic Expansion
Slide 5: Q1 FY27 Performance Snapshot
Q1 FY27 Performance Snapshot Financial Performance Key Metrics 1.24 Mn 4.59 Mn INR 2,310 Mn Footfall Tests Revenue from Operations INR 985 Mn | 42.7% INR 531 Mn | 23.0% 166 (1) 92% EBITDA | EBITDA Margin % PAT | PAT Margin % Centres B2C Revenue % YOY Growth % Geographical Contribution Wellness Share
Slide 6: Management Commentary
Management Commentary “ I’m pleased to start on a positive note, as we delivered robust year-on-year revenue growth of approximately 22.8%, supported by volume growth of nearly 16.5% in Q1 FY 27. Coming to PH, we delivered year-on-year growth of approximately 18%, primarily driven by network expansi
Slide 7: Key Financial Highlights
Key Financial Highlights (INR Mn) Revenue from Operations EBITDA & EBITDA Margin % PAT & PAT Margin % 39.1% 43.5% 42.7% 40.1% 41.4% 20.5% 21.8% 23.0% 21.1% 21.2% 8,142 6,814 3,369 2,732 1,730 Key 1,438 Financials 1,881 2,194 2,310 955 985 479 531 735 386 Q1 FY26 Q4 FY26 Q1 FY27 FY25 FY26 Q1 FY26 Q4
Slide 8: Key Operational Highlights
Key Operational Highlights (INR Mn) Tests Performed (# in Mn) Footfalls (# in Mn) Tests / Footfalls (#) 4.68 16.92 4.19 3.70 3.70 14.79 3.62 3.58 3.53 4.49 4.59 1.10 1.21 1.24 3.94 Q1 FY26 Q4 FY26 Q1 FY27 FY25 FY26 Q1 FY26 Q4 FY26 Q1 FY27 FY25 FY26 Q1 FY26 Q4 FY26 Q1 FY27 FY25 FY26 Revenue per Test
Slide 9: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement (INR Mn) Particulars Q1 FY27 Q1 FY26 Y-o-Y Q4 FY26 Q-o-Q FY26 FY25 Y-o-Y Revenue from operations 2,309.8 1,880.5 22.8% 2,193.8 5.3% 8,142.0 6,813.9 19.5% Cost of materials consumed 256.0 214.1 19.5% 249.3 2.7% 946.8 847.6 11.7% Gross Profit 2,053.9 1,666.4 23.3%
Slide 10: Sustained Momentum Observed Across the Wellness Segment
Sustained Momentum Observed Across the Wellness Segment High Volume of Wellness testing being observed in younger 1 population due to increased awareness & growing chronic disease burden due to stress, sedentary life & shift in lifestyle patterns Adoption of wellness testing is scaling across market
Slide 11: Key Developments
Key Developments Strategic Expansion
Slide 12: Launched State-of-the-Art Flagship Hub in JP Nagar, Bengaluru (1/2)
1 Launched State-of-the-Art Flagship Hub in JP Nagar, Bengaluru (1/2) Inaugurated State-of-the-Art Hub in JP Nagar in the 2nd week of July, 2026 in line with our strategy of expanding organically in Bengaluru JP Nagar 10,000+ sq.ft. Hub houses The Wide Bore 3T Omega MRI is first advanced equipment l
Slide 13: Launched State-of-the-Art Flagship Hub in JP Nagar, Bengaluru (2/2)
1 Launched State-of-the-Art Flagship Hub in JP Nagar, Bengaluru (2/2) Inaugurated State-of-the-Art Hub in JP Nagar in the 2nd week of July, 2026 in line with our strategy of expanding organically in Bengaluru JP Nagar 10,000+ sq.ft. Hub also houses full-fledged lab Strategically located in which wil
Slide 14: Inaugurated a Hub centre in Hyderabad (1/2)
2 Inaugurated a Hub centre in Hyderabad (1/2) Inaugurated a Hub Centre in Gachibowli, Hyderabad in April, 2026 13
Slide 15: Inaugurated a Hub centre in Hyderabad (1/2)
2 Inaugurated a Hub centre in Hyderabad (1/2) Inaugurated a wellness centre Inaugurated in Gachibowli, a Hub Centre Hyderabad in Gachibowli, in April, 2026 Hyderabad offeringin integrated, April, 2026 holistic health assessments 14
Slide 16: Inaugurated Spokes in Hyderabad
3 Inaugurated 2 Spokes in Hyderabad Inaugurated 2 Spokes in June, 2026 in Hyderabad in line with our strategy of building dense network and deepening marketing penetration Ramanthapur Chintalmet Hyderabad 15
Slide 17: Inaugurated Spokes in AP
4 Inaugurated 2 Spokes in AP Inaugurated 2 Spokes in June & July 2026 respectively in AP as part of our strategy to consolidate our presence in Core Geographies Muralinagar (Vizag) Vishakapatnam Magunta Layout (Nellore) Nellore 16
Slide 18: Launched a Spoke in Kharadi, Pune
5 Launched a Spoke in Kharadi, Pune Inaugurated a Spoke in June, 2026 in Kharadi in line with our strategy of strategy of expansion in Pune post PH acquisition Kharadi 17
Slide 19: Leveraging the Transformative Power of AI for CT KUB Cases Reporting
Leveraging the Transformative Power of AI for CT KUB Cases Reporting Automated Stone Detection & Intelligent Differentiation 3D Localization ▪ Auto-locates & measures ▪ Distinguishes true kidney stones stones from harmless pelvic vein calcifications and ▪ Precise 3D localization of vascular spots in
Slide 20: AI-Powered Dental Diagnostics for Precision Care
AI-Powered Dental Diagnostics for Precision Care ➢ AI dental diagnostics platform delivers high-precision 2D/3D radiograph analysis, predictive care, and clinical decision support ➢ Al-based 2D & CBCT scan analysis for faster, more accurate diagnostics ➢ Enhances patient outcomes & trust with visual
Slide 21: Strategic Expansion
Strategic Expansion Strategic Expansion
Slide 22: Expanding Strategically in Alignment with our Vision
Expanding Strategically in Alignment with our Vision Inorganic Expansion Strategy • Successfully acquired PH, Pune's largest B2C integrated diagnostic chain • This strategic acquisition seamlessly aligns East India Strategy with our commitment to providing top-notch healthcare services at affordable
Slide 23: Expansion Plans - Upcoming Hubs and Spokes Centres
Expansion Plans - Upcoming Hubs and Spokes Centres Tentative Timelines Geography Launched till date in FY27 Upcoming H1 FY27 for Commencement Hyderabad 1 Hub 1 Spoke H1 FY27 3 Spokes 1 Spoke H2 FY27 2 7 Hubs Spokes 1 Hub H2 FY27 RoAPT 2 Spokes 1 Spoke H2 FY27 H2 FY27 1 Hub H1 FY28 1 Hub 2 Hubs H2 FY
Slide 24: Company Overview
Company Overview Strategic Expansion
Slide 25: Vijaya at a Glance
Vijaya at a Glance Vijaya Diagnostic is the largest integrated B2C focused diagnostic chain in India with 166 state-of-the-art centres spread across 27 cities & towns Evolved from a regional player to a player with presence in multiple geographies … … While retaining its core values of providing Qua
Slide 26: Our Journey
Our Journey 1981 1993 1995 2007 20032012 2005 2016 ▪ Vijaya Diagnostic Centre ▪ Became 1st independent diagnostic ▪ Recognized as one of the Best ▪ Received investment from incorporated in Hyderabad centre in South India to offer PET CT Imaging centres in Hyderabad Karakoram Limited & Kedaara from W
Slide 27: Integrated Diagnostics Player Offering One-Stop Solution
Integrated Diagnostics Player Offering One-Stop Solution Complete Range of Diagnostic Services under One Roof Robust operational network enables us to offer integrated, high-quality diagnostic services that significantly elevate the customer experience 37.2 62.8 % Pathology (1) % Radiology (1) 26 1.
Slide 28: Dominant Position in Telangana & AP Markets with a Strong Brand Recall
Dominant Position in Telangana & AP Markets with a Strong Brand Recall Vijaya has been successful in creating a dense market consolidating its foothold in its core geographies of AP & Telangana markets Present in Key Geographies of AP & Telangana 67 (1) % Hyderabad Revenue Contribution Nizamabad Man
Slide 29: Strong Traction observed in Newer Geographies (1/3)
Strong Traction observed in Newer Geographies (1/3) Differentiated offering has accelerated Vijaya’s success in new geographies West Bengal Network Greater Kolkata Area Network West Bengal Krishnanagar Greater Kolkata Area Diamond Harbour Faster break-even’s enable replication of densification strat
Slide 30: Strong Traction observed in Newer Geographies (2/3)
Strong Traction observed in Newer Geographies (2/3) Differentiated offering has accelerated Vijaya Brand’s success in new geographies Pune Network Pune Faster break-even’s enable replication of densification strategy in newer geographies 29 Existing Centres
Slide 31: Strong Traction observed in Newer Geographies (3/3)
Strong Traction observed in Newer Geographies (3/3) Differentiated offering has accelerated Vijaya Brand’s success in new geographies Bengaluru Network Kalaburagi Bengaluru Mysore Faster break-even’s enable replication of densification strategy in newer geographies 30 Existing Centres Upcoming Hub i
Slide 32: Driving Geographical Diversification through Strategic Expansion
Driving Geographical Diversification through Strategic Expansion Gurgaon Hyderabad Pune RoAPT West Bengal Kalaburagi Bengaluru 69% 72% 67% 67% 21% 20% 20% 18% Geographical 6% 6% 6% 6% 7% 7% Revenue Mix 6% 4% Q1 FY27 Q4 FY26 FY26 FY25 Q1 FY27 Q4 FY26 FY26 FY25 Q1 FY27 Q4 FY26 FY26 FY25 Q1 FY27 Q4 FY2
Slide 33: Boosting Accessibility with Best-in-class Online Services & Home Collections
Boosting Accessibility with Best-in-class Online Services & Home Collections Online Services Home Collections Enhancing Customer Experience through Seamless Online App, E-Commerce Website and Call Centre Bookings Elevating Customer Experience through Home Collections Access to reports online & histo
Slide 34: Robust Technical Capabilities with State-of-the-art IT Infrastructure
Robust Technical Capabilities with State-of-the-art IT Infrastructure 41 9 Advanced Software to Manage Clinical Data CT Machines PET CT / Gamma machines 43 350+ MRI Machines Fully Integrated Radiology Radiologists, Lab Doctors & Advance Laboratory Information Systems (RIS) and Physicians Information
Slide 35: Experienced Board of Directors
Experienced Board of Directors Founder & Managing Director Executive Director Non-Executive Chairman & CEO Director Dr. S. Surendranath Ms. Suprita Reddy Mr. Sunil Chandra Ms. S Geeta Reddy Reddy Kondapally ✔ 40+ years of experience ✔ 22+ years of experience ✔ 22+ years of experience ✔ 35+ years of
Slide 36: Stellar Management Team
Stellar Management Team Founder & Chairman Managing Director & CEO Executive Director Dr. S. Surendranath Suprita Reddy Sunil Chandra Reddy Kondapally Chief Operating Officer Chief Financial Officer Director - Laboratory Director - Radiology Sivaramaraju Narasimha Raju K.A Dr. Kiran B Dr. V Vijayana
Slide 37: Shareholding Pattern as at 30th June, 2026
Shareholding Pattern as at 30th June, 2026 Shareholding Pattern as at 30th June, 2026 Others 4.2% FIIs 11.7% Promoter & Promoter Group 52.5% DIIs 31.6% DIIs: Mutual Funds, AIFs and QIBs FIIs: Hedge Funds, Sovereign Wealth Funds, Foreign MFs, Pension Funds, Trusts and AMCs Others: Retail, Bodies Corp
Slide 38: Doctors Connect Program in Q1 FY27
Doctors Connect Program in Q1 FY27 37
Slide 39: Awards & Accolades
Awards & Accolades Best Healthcare Brands Most Preferred Workplace Icon in Integrated Diagnostic Best Diagnostic Centre Icon in Integrated Diagnostic 2026 recognized by ET Edge 2026-27 recognized by Services by Times Health awarded at HMTV Healthcare Services by Times Health Marksmen Daily Excellenc
Slide 40: Annexure
Annexure Strategic Expansion
Slide 41: State-of-the-art Infrastructure (1/3)
State-of-the-art Infrastructure (1/3) 40
Slide 42: State-of-the-art Infrastructure (2/3)
State-of-the-art Infrastructure (2/3) 41
Slide 43: State-of-the-art Infrastructure (3/3)
State-of-the-art Infrastructure (3/3) 42
Slide 44: Advanced Equipment in Place to Deliver High Quality Services (1/2)
Advanced Equipment in Place to Deliver High Quality Services (1/2) 43
Slide 45: Advanced Equipment in Place to Deliver High Quality Services (2/2)
Advanced Equipment in Place to Deliver High Quality Services (2/2) 44
Slide 46: Robust Operational Metrics
Robust Operational Metrics Diagnostic Centre (Nos) Footfalls (Mn) Tests Performed (Mn) 4.68 162 4.19 16.92 145 151 3.62 3.55 14.79 121 3.18 11.89 95 9.32 10.05 FY22 FY23 FY24 FY25 FY26 FY22 FY23 FY24 FY25 FY26 FY22 FY23 FY24 FY25 FY26 Test per Footfall (Nos) Revenue per Test (INR) Revenue per Footfa
Slide 47: Consistent Financial Performance
Consistent Financial Performance (INR Mn) Revenue EBIDTA PAT Impact of Impact of Impact of COVID-19 8,142 COVID-19 3,369 COVID-19 1,730 6,814 2,732 1,438 5,478 2,209 1,097 1,188 4,624 4,592 2,037 1,820 846 FY22 FY23 FY24 FY25 FY26 FY22 FY23 FY24 FY25 FY26 FY22 FY23 FY24 FY25 FY26 EBIDTA Margin (%) P
Slide 48: Sustainable Cash Generation & Increasing Return Ratios
Sustainable Cash Generation & Increasing Return Ratios Surplus Cash (INR Mn) CFO (1) / EBIDTA (%) 2,869 90% 2,465 2,554 2,067 1,851 83% 82% 80% 78% FY22 FY23 FY24 FY25 FY26 FY22 FY23 FY24 FY25 FY26 RoCE Pre-Tax (2) (%) RoE (3) (%) 46% 27% 20% 20% 20% 26% 26% 17% 25% 25% FY22 FY23 FY24 FY25 FY26 FY22
Slide 49: Consolidated Profit & Loss Account
Consolidated Profit & Loss Account (INR Mn) Particulars FY22 FY23 FY24 FY25 FY26 Revenue from operations 4,624 4,592 5,478 6,814 8,142 Cost of materials consumed 715 589 654 848 947 Employee benefits expense 707 785 902 1,122 1,307 Other expenses 1,165 1,398 1,712 2,113 2,518 EBITDA 2,037 1,820 2,20
Slide 50: Consolidated Balance Sheet
Consolidated Balance Sheet (INR Mn) ASSETS Mar-22 Mar-23 Mar-24 Mar-25 Mar-26 EQUITY & LIABILITIES Mar-22 Mar-23 Mar-24 Mar-25 Mar-26 NON-CURRENT ASSETS 4,436 5,777 7,714 9,664 11,851 EQUITY 4,695 5,466 6,599 7,991 9,572 Property, plant and equipment 1,966 2,940 3,785 4,469 5,625 Equity share capita
Slide 51: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement (INR Mn) Particulars Mar-22 Mar-23 Mar-24 Mar-25 Mar-26 Cash Flow from Operating Activities Profit before Tax 1,474 1,135 1,587 1,932 2,327 Adjustment for Non-Operating Items 572 683 599 786 1,070 Operating Profit before Working Capital Changes 2,046 1,818 2,186 2,71
Slide 52: Thank You
Thank You For further information please contact: Mr. Dhiren Gala Head - Investor Relations & Corporate Development +91 90598 93206 [email protected] [email protected] www.vijayadiagnostic.com Corporate Office : #6-3-883/F, FPA Building, Near Topaz Building, Punjagutta, Hyderabad-500
Vijaya Diagnostic Centre — Q1 FY27 Earnings Presentation on 6ix